Listar por autor "N'TAKPE, Jean-Baptiste"

Las cookies de este sitio web no contienen ninguna clase de información personal específica, solo permiten recoger datos sobre su navegación. Más información…

Listar por autor "N'TAKPE, Jean-Baptiste"

Chimioprophylaxie antituberculeuse primaire à l'isoniazide : une stratégie d'actualité à l’ère du tester et traiter ; revue de la littérature

Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adults

Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts

Higher Risk of Mortality in HIV-HBV Co-Infected Patients from Sub-Saharan Africa Is Observed at Lower CD4 \textsuperscript+ Cell Counts

Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults

Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis

Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial

Determinants of attendance in antenatal care clinics in rural settings in Mali and Burkina Faso: a cross-sectional study

Tuberculosis disease characteristics associated with mortality, severe morbidity and unsuccessful treatment in people living with HIV treated for tuberculosis - a secondary analysis of the ANRS 12300 Reflate TB2 trial

Listar por autor "N'TAKPE, Jean-Baptiste"

Chimioprophylaxie antituberculeuse primaire à l'isoniazide : une stratégie d'actualité à l’ère du tester et traiter ; revue de la littérature ﻿

Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adults ﻿

Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts ﻿

Higher Risk of Mortality in HIV-HBV Co-Infected Patients from Sub-Saharan Africa Is Observed at Lower CD4 \textsuperscript+ Cell Counts ﻿

Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults ﻿

Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation ﻿

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis ﻿

Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial ﻿

Determinants of attendance in antenatal care clinics in rural settings in Mali and Burkina Faso: a cross-sectional study ﻿

Tuberculosis disease characteristics associated with mortality, severe morbidity and unsuccessful treatment in people living with HIV treated for tuberculosis - a secondary analysis of the ANRS 12300 Reflate TB2 trial ﻿

Chimioprophylaxie antituberculeuse primaire à l'isoniazide : une stratégie d'actualité à l’ère du tester et traiter ; revue de la littérature

Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adults

Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts

Higher Risk of Mortality in HIV-HBV Co-Infected Patients from Sub-Saharan Africa Is Observed at Lower CD4 \textsuperscript+ Cell Counts

Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults

Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis

Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial

Determinants of attendance in antenatal care clinics in rural settings in Mali and Burkina Faso: a cross-sectional study

Tuberculosis disease characteristics associated with mortality, severe morbidity and unsuccessful treatment in people living with HIV treated for tuberculosis - a secondary analysis of the ANRS 12300 Reflate TB2 trial